| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemangioma, Cavernous, Central Nervous System | 52 | 2024 | 227 | 9.470 |
Why?
|
| Hemorrhage | 24 | 2023 | 276 | 2.080 |
Why?
|
| rho-Associated Kinases | 11 | 2019 | 161 | 1.900 |
Why?
|
| Brain Neoplasms | 11 | 2022 | 775 | 1.700 |
Why?
|
| Hemangioma, Cavernous | 8 | 2021 | 69 | 1.440 |
Why?
|
| Apoptosis Regulatory Proteins | 13 | 2021 | 201 | 1.380 |
Why?
|
| Intracranial Arteriovenous Malformations | 8 | 2011 | 109 | 1.110 |
Why?
|
| Disease Models, Animal | 16 | 2024 | 2340 | 1.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2019 | 385 | 1.040 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 6 | 2020 | 36 | 1.030 |
Why?
|
| Central Nervous System Neoplasms | 5 | 2019 | 85 | 1.010 |
Why?
|
| NF-kappa B | 14 | 2003 | 464 | 0.920 |
Why?
|
| Lung | 19 | 2023 | 1242 | 0.920 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2023 | 3433 | 0.900 |
Why?
|
| Proto-Oncogene Proteins | 14 | 2021 | 661 | 0.900 |
Why?
|
| Intracranial Hemorrhages | 3 | 2021 | 124 | 0.830 |
Why?
|
| Endothelial Cells | 15 | 2024 | 453 | 0.760 |
Why?
|
| KRIT1 Protein | 14 | 2022 | 62 | 0.740 |
Why?
|
| Mice | 44 | 2024 | 11696 | 0.730 |
Why?
|
| Simvastatin | 2 | 2019 | 105 | 0.710 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2001 | 68 | 0.700 |
Why?
|
| Endotoxemia | 6 | 2001 | 18 | 0.660 |
Why?
|
| Enzyme Inhibitors | 3 | 2019 | 645 | 0.650 |
Why?
|
| Cerebral Hemorrhage | 7 | 2023 | 335 | 0.630 |
Why?
|
| Biomarkers | 15 | 2023 | 1754 | 0.610 |
Why?
|
| Capillary Permeability | 6 | 2021 | 130 | 0.580 |
Why?
|
| Membrane Proteins | 6 | 2021 | 1213 | 0.580 |
Why?
|
| Animals | 52 | 2024 | 27171 | 0.570 |
Why?
|
| Mutation | 12 | 2021 | 4092 | 0.520 |
Why?
|
| Cytokines | 7 | 2017 | 801 | 0.450 |
Why?
|
| Microtubule-Associated Proteins | 9 | 2022 | 183 | 0.450 |
Why?
|
| Propranolol | 3 | 2022 | 44 | 0.440 |
Why?
|
| Neutrophil Activation | 4 | 2002 | 11 | 0.430 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2023 | 63 | 0.420 |
Why?
|
| Male | 54 | 2024 | 41926 | 0.410 |
Why?
|
| Humans | 60 | 2024 | 88416 | 0.390 |
Why?
|
| Mice, Inbred BALB C | 16 | 2002 | 1084 | 0.380 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2019 | 603 | 0.370 |
Why?
|
| Brain | 10 | 2020 | 2257 | 0.370 |
Why?
|
| Transcriptome | 5 | 2024 | 619 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2024 | 421 | 0.350 |
Why?
|
| Carrier Proteins | 6 | 2019 | 679 | 0.330 |
Why?
|
| Mice, Knockout | 9 | 2024 | 1987 | 0.320 |
Why?
|
| Neutrophils | 6 | 2002 | 308 | 0.320 |
Why?
|
| Resuscitation | 5 | 1995 | 105 | 0.320 |
Why?
|
| Iron | 4 | 2018 | 166 | 0.310 |
Why?
|
| Adult | 22 | 2023 | 26280 | 0.300 |
Why?
|
| Central Nervous System Vascular Malformations | 2 | 2023 | 33 | 0.300 |
Why?
|
| X-Ray Microtomography | 2 | 2019 | 81 | 0.300 |
Why?
|
| Female | 35 | 2024 | 45652 | 0.290 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 1570 | 0.290 |
Why?
|
| Lipopolysaccharides | 6 | 2020 | 292 | 0.290 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 2 | 2023 | 15 | 0.270 |
Why?
|
| Kruppel-Like Transcription Factors | 4 | 2021 | 98 | 0.260 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 267 | 0.260 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2019 | 379 | 0.250 |
Why?
|
| Sirolimus | 2 | 2023 | 173 | 0.250 |
Why?
|
| Macrophages, Alveolar | 5 | 2000 | 57 | 0.250 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2019 | 1226 | 0.250 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2024 | 8 | 0.240 |
Why?
|
| Chemokine CX3CL1 | 1 | 2024 | 6 | 0.240 |
Why?
|
| B-Lymphocytes | 5 | 2018 | 736 | 0.240 |
Why?
|
| RNA, Messenger | 13 | 2021 | 2006 | 0.240 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2020 | 489 | 0.230 |
Why?
|
| Astrocytes | 2 | 2021 | 141 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 4 | 2024 | 364 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 3 | 2022 | 68 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2003 | 699 | 0.220 |
Why?
|
| Inflammation Mediators | 3 | 2021 | 155 | 0.220 |
Why?
|
| Young Adult | 10 | 2021 | 6189 | 0.220 |
Why?
|
| Disease Progression | 4 | 2021 | 1489 | 0.220 |
Why?
|
| Child, Preschool | 7 | 2020 | 3669 | 0.220 |
Why?
|
| Arteriovenous Malformations | 1 | 2023 | 41 | 0.210 |
Why?
|
| Prospective Studies | 8 | 2023 | 4265 | 0.210 |
Why?
|
| Adolescent | 11 | 2020 | 9135 | 0.210 |
Why?
|
| Plasma Cells | 3 | 2020 | 81 | 0.210 |
Why?
|
| Signal Transduction | 6 | 2024 | 3363 | 0.210 |
Why?
|
| Gene Expression | 4 | 2003 | 1311 | 0.210 |
Why?
|
| Circulating MicroRNA | 1 | 2022 | 13 | 0.210 |
Why?
|
| Middle Aged | 20 | 2021 | 25626 | 0.210 |
Why?
|
| Catecholamines | 2 | 1999 | 92 | 0.200 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2021 | 7 | 0.190 |
Why?
|
| ADAMTS5 Protein | 1 | 2020 | 4 | 0.190 |
Why?
|
| Versicans | 1 | 2020 | 8 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 3196 | 0.190 |
Why?
|
| Child | 8 | 2020 | 7079 | 0.190 |
Why?
|
| Perfusion Imaging | 1 | 2021 | 50 | 0.190 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 2 | 2021 | 13 | 0.190 |
Why?
|
| Microfilament Proteins | 3 | 2018 | 212 | 0.190 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 577 | 0.190 |
Why?
|
| Gene Deletion | 3 | 2020 | 341 | 0.180 |
Why?
|
| Brain Stem | 1 | 2021 | 167 | 0.180 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2019 | 91 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 6 | 2008 | 927 | 0.180 |
Why?
|
| Cohort Studies | 7 | 2021 | 2832 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 226 | 0.180 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 39 | 0.180 |
Why?
|
| Xanthine Oxidase | 4 | 2001 | 25 | 0.170 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 74 | 0.170 |
Why?
|
| Autoantigens | 1 | 2020 | 129 | 0.170 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 727 | 0.160 |
Why?
|
| Autoantibodies | 1 | 2020 | 268 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2001 | 443 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 2 | 2021 | 222 | 0.160 |
Why?
|
| Stroke | 3 | 2023 | 978 | 0.160 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 1996 | 124 | 0.150 |
Why?
|
| Thrombospondin 1 | 1 | 2017 | 21 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1142 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 190 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 1999 | 487 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2022 | 551 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 2019 | 0.140 |
Why?
|
| Permeability | 3 | 2021 | 137 | 0.140 |
Why?
|
| Temporal Arteries | 2 | 2009 | 9 | 0.140 |
Why?
|
| Cells, Cultured | 6 | 2017 | 2873 | 0.140 |
Why?
|
| DNA, Mitochondrial | 1 | 1996 | 187 | 0.130 |
Why?
|
| Bayes Theorem | 3 | 2022 | 367 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2023 | 3652 | 0.130 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1044 | 0.130 |
Why?
|
| Endothelium, Vascular | 4 | 2020 | 433 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2009 | 2322 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2019 | 85 | 0.130 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 165 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 197 | 0.130 |
Why?
|
| Pregnatrienes | 1 | 1995 | 14 | 0.130 |
Why?
|
| P-Selectin | 1 | 1995 | 13 | 0.130 |
Why?
|
| Genetic Therapy | 1 | 2017 | 357 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1995 | 71 | 0.120 |
Why?
|
| Genes, MHC Class II | 2 | 1993 | 30 | 0.120 |
Why?
|
| Keratin-1 | 1 | 2014 | 2 | 0.120 |
Why?
|
| Seizures | 1 | 2017 | 302 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 408 | 0.120 |
Why?
|
| Stress Fibers | 1 | 2014 | 24 | 0.120 |
Why?
|
| Aged | 10 | 2021 | 18887 | 0.120 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 1424 | 0.120 |
Why?
|
| Peyer's Patches | 1 | 1994 | 18 | 0.120 |
Why?
|
| Machine Learning | 3 | 2021 | 241 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 87 | 0.120 |
Why?
|
| Infant | 2 | 2014 | 3111 | 0.110 |
Why?
|
| Vitamin D | 1 | 2016 | 267 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2017 | 427 | 0.110 |
Why?
|
| Antioxidants | 1 | 1995 | 225 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 681 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 1401 | 0.110 |
Why?
|
| Contrast Media | 4 | 2021 | 1087 | 0.110 |
Why?
|
| Chemokine CXCL2 | 3 | 2001 | 16 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 1993 | 441 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 321 | 0.100 |
Why?
|
| Acute Disease | 3 | 2020 | 838 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 231 | 0.100 |
Why?
|
| Deoxyribonuclease I | 1 | 1991 | 28 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 146 | 0.100 |
Why?
|
| Inflammation | 4 | 2011 | 961 | 0.090 |
Why?
|
| Base Sequence | 9 | 2005 | 2331 | 0.090 |
Why?
|
| Chronic Disease | 3 | 2020 | 948 | 0.090 |
Why?
|
| Enzyme Activation | 3 | 2001 | 698 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 2743 | 0.090 |
Why?
|
| Perfusion | 2 | 2021 | 226 | 0.090 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2001 | 31 | 0.090 |
Why?
|
| Genotype | 4 | 2021 | 1867 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 1975 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2000 | 1642 | 0.090 |
Why?
|
| Observer Variation | 3 | 2016 | 607 | 0.080 |
Why?
|
| Phenotype | 4 | 2020 | 2432 | 0.080 |
Why?
|
| Interferon-gamma | 3 | 1996 | 451 | 0.080 |
Why?
|
| Ethers | 1 | 2008 | 14 | 0.080 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2008 | 49 | 0.080 |
Why?
|
| Microdissection | 1 | 2008 | 18 | 0.080 |
Why?
|
| I-kappa B Proteins | 2 | 2000 | 54 | 0.080 |
Why?
|
| Medical Illustration | 1 | 2008 | 16 | 0.080 |
Why?
|
| Magnetics | 1 | 2008 | 41 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2008 | 73 | 0.080 |
Why?
|
| Point Mutation | 1 | 2009 | 246 | 0.080 |
Why?
|
| Lasers | 1 | 2008 | 107 | 0.080 |
Why?
|
| Fluorocarbons | 1 | 2008 | 72 | 0.080 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 78 | 0.080 |
Why?
|
| Oligoclonal Bands | 1 | 2007 | 5 | 0.080 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2018 | 23 | 0.080 |
Why?
|
| Intracranial Aneurysm | 1 | 2009 | 164 | 0.080 |
Why?
|
| Myocardium | 2 | 2003 | 570 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2021 | 523 | 0.070 |
Why?
|
| Cell Movement | 3 | 1999 | 783 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 466 | 0.070 |
Why?
|
| Endotoxins | 2 | 1999 | 36 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2020 | 635 | 0.070 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1986 | 25 | 0.070 |
Why?
|
| Neoplasms | 1 | 2021 | 2999 | 0.070 |
Why?
|
| Interleukin-1 | 3 | 2000 | 71 | 0.070 |
Why?
|
| Molecular Sequence Data | 5 | 2005 | 3028 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 697 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2020 | 865 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 66 | 0.060 |
Why?
|
| Laminin | 1 | 2005 | 89 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 588 | 0.060 |
Why?
|
| Transcription Factor RelA | 2 | 2001 | 49 | 0.060 |
Why?
|
| Myosins | 1 | 2005 | 90 | 0.060 |
Why?
|
| DNA Repair | 2 | 1986 | 359 | 0.060 |
Why?
|
| Fibronectins | 1 | 2005 | 102 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1641 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2001 | 101 | 0.060 |
Why?
|
| Chemokines | 2 | 2001 | 74 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1848 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2005 | 134 | 0.060 |
Why?
|
| Phentolamine | 2 | 2001 | 8 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 226 | 0.060 |
Why?
|
| Interleukins | 2 | 1995 | 136 | 0.060 |
Why?
|
| T-Lymphocytes | 3 | 2018 | 1220 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2004 | 143 | 0.060 |
Why?
|
| Genomics | 1 | 2009 | 740 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2001 | 1156 | 0.060 |
Why?
|
| Collagen | 1 | 2005 | 293 | 0.060 |
Why?
|
| Aging | 2 | 2020 | 710 | 0.050 |
Why?
|
| Peroxidase | 2 | 2000 | 51 | 0.050 |
Why?
|
| Time Factors | 3 | 2018 | 5302 | 0.050 |
Why?
|
| Integrin beta1 | 1 | 2022 | 33 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2003 | 59 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 78 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 1788 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 131 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2005 | 341 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 161 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2003 | 174 | 0.050 |
Why?
|
| CREB-Binding Protein | 1 | 2001 | 16 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 456 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2009 | 392 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 13 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2001 | 68 | 0.050 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 29 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2011 | 30 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 234 | 0.050 |
Why?
|
| Tungsten | 1 | 2001 | 5 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 519 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2021 | 89 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2021 | 99 | 0.050 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2001 | 15 | 0.050 |
Why?
|
| Animal Feed | 1 | 2001 | 20 | 0.050 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 22 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 44 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 36 | 0.050 |
Why?
|
| ADAMTS4 Protein | 1 | 2020 | 4 | 0.050 |
Why?
|
| ADAMTS1 Protein | 1 | 2020 | 6 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 71 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 77 | 0.050 |
Why?
|
| Hemoptysis | 1 | 2000 | 24 | 0.050 |
Why?
|
| Patient Participation | 1 | 2023 | 223 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 39 | 0.050 |
Why?
|
| Cell Line | 3 | 1996 | 2498 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 33 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2020 | 150 | 0.050 |
Why?
|
| Cholecalciferol | 1 | 2020 | 35 | 0.050 |
Why?
|
| Plasma | 1 | 2020 | 51 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 102 | 0.050 |
Why?
|
| Vimentin | 1 | 2020 | 46 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2001 | 104 | 0.050 |
Why?
|
| Spin Labels | 1 | 2020 | 105 | 0.040 |
Why?
|
| Tubulin | 1 | 2020 | 58 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 155 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2003 | 729 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 449 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 106 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 92 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 294 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 185 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 279 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2019 | 68 | 0.040 |
Why?
|
| Monokines | 1 | 1999 | 3 | 0.040 |
Why?
|
| White Matter | 1 | 2020 | 83 | 0.040 |
Why?
|
| Metagenomics | 1 | 2020 | 88 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2021 | 146 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 168 | 0.040 |
Why?
|
| Protein Binding | 2 | 2016 | 1484 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 238 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 246 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 307 | 0.040 |
Why?
|
| Patient Selection | 1 | 2023 | 689 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2023 | 8139 | 0.040 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1999 | 33 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1246 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 294 | 0.040 |
Why?
|
| Hypoxia | 1 | 2024 | 650 | 0.040 |
Why?
|
| Feces | 1 | 2020 | 326 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 439 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 314 | 0.040 |
Why?
|
| Occludin | 1 | 2018 | 66 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 314 | 0.040 |
Why?
|
| DNA Replication | 4 | 1986 | 169 | 0.040 |
Why?
|
| Ischemia | 1 | 2000 | 251 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 81 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2021 | 407 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2019 | 344 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 684 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 223 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 328 | 0.040 |
Why?
|
| Methylation | 2 | 1991 | 266 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 48 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 333 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 1204 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 35 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2017 | 75 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 241 | 0.040 |
Why?
|
| Intestines | 1 | 2020 | 415 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 450 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2018 | 260 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 306 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 771 | 0.040 |
Why?
|
| Hyperoxia | 1 | 1996 | 35 | 0.040 |
Why?
|
| Colitis | 1 | 2019 | 241 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 289 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2000 | 1238 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2016 | 36 | 0.030 |
Why?
|
| Leucine Zippers | 1 | 1996 | 10 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 39 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2016 | 11 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 35 | 0.030 |
Why?
|
| Cerebellum | 1 | 2018 | 249 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 371 | 0.030 |
Why?
|
| Clone Cells | 1 | 1996 | 214 | 0.030 |
Why?
|
| Iodine | 1 | 2016 | 43 | 0.030 |
Why?
|
| Catalase | 1 | 1996 | 49 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 377 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 199 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2016 | 55 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 773 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1712 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 686 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 367 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 181 | 0.030 |
Why?
|
| Phosphatidic Acids | 1 | 1995 | 4 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 1646 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 656 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 1996 | 177 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 891 | 0.030 |
Why?
|
| Spleen | 1 | 1996 | 431 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 193 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 203 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 1145 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 803 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2014 | 20 | 0.030 |
Why?
|
| Models, Biological | 2 | 2020 | 1764 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2014 | 18 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 9 | 0.030 |
Why?
|
| Meiosis | 2 | 1993 | 82 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 1994 | 98 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2285 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1994 | 126 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1994 | 205 | 0.030 |
Why?
|
| Gadolinium | 1 | 2013 | 103 | 0.030 |
Why?
|
| Monocytes | 1 | 1994 | 217 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3747 | 0.030 |
Why?
|
| Pneumonia | 1 | 1994 | 183 | 0.030 |
Why?
|
| Apoptosis | 1 | 1999 | 1715 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 465 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2010 | 1129 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 299 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1519 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 774 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1996 | 942 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 156 | 0.020 |
Why?
|
| Breeding | 1 | 2010 | 40 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 280 | 0.020 |
Why?
|
| Testis | 1 | 1991 | 152 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2015 | 402 | 0.020 |
Why?
|
| Edema, Cardiac | 1 | 2010 | 3 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2010 | 68 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2010 | 29 | 0.020 |
Why?
|
| Genes | 1 | 1991 | 305 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2013 | 564 | 0.020 |
Why?
|
| Animal Structures | 1 | 2010 | 22 | 0.020 |
Why?
|
| Introns | 1 | 1991 | 298 | 0.020 |
Why?
|
| Brain Edema | 1 | 2010 | 50 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2010 | 50 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 59 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6706 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2000 | 42 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 82 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 178 | 0.020 |
Why?
|
| Binding Sites | 1 | 1991 | 1113 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 558 | 0.020 |
Why?
|
| Immune System | 1 | 2009 | 97 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 531 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 684 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 2006 | 30 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 1986 | 239 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2006 | 48 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2000 | 594 | 0.020 |
Why?
|
| DNA Polymerase I | 1 | 1986 | 9 | 0.020 |
Why?
|
| Mitosis | 1 | 1986 | 152 | 0.020 |
Why?
|
| Kinetics | 2 | 1986 | 1528 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 1234 | 0.020 |
Why?
|
| Macrophages | 1 | 2009 | 572 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 315 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 478 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 182 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 452 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1986 | 604 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 153 | 0.010 |
Why?
|
| Rats | 2 | 2000 | 4032 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2000 | 1841 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 1986 | 604 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 863 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 1131 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2061 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 259 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 575 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2000 | 1 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2000 | 26 | 0.010 |
Why?
|
| Neutropenia | 1 | 2000 | 216 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 340 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2000 | 42 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2000 | 142 | 0.010 |
Why?
|
| DNA | 1 | 1985 | 1308 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 285 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2000 | 139 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1997 | 15 | 0.010 |
Why?
|
| Allopurinol | 1 | 1997 | 78 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1997 | 111 | 0.010 |
Why?
|
| Templates, Genetic | 2 | 1985 | 34 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1995 | 9 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1996 | 289 | 0.010 |
Why?
|
| Homeostasis | 1 | 1997 | 407 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 38 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1995 | 41 | 0.010 |
Why?
|
| DNA, Single-Stranded | 2 | 1985 | 92 | 0.010 |
Why?
|
| Heart | 1 | 1997 | 572 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1995 | 425 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1993 | 371 | 0.010 |
Why?
|
| Plasmids | 1 | 1993 | 292 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 1056 | 0.010 |
Why?
|
| Transfection | 1 | 1993 | 912 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1993 | 754 | 0.010 |
Why?
|
| Larva | 1 | 1986 | 119 | 0.000 |
Why?
|
| Sulfuric Acid Esters | 1 | 1985 | 4 | 0.000 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1985 | 16 | 0.000 |
Why?
|
| Alkylating Agents | 1 | 1985 | 32 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1986 | 390 | 0.000 |
Why?
|
| Adenine | 1 | 1985 | 88 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1985 | 995 | 0.000 |
Why?
|